Stocks
Inovio Pharmaceuticals, Inc.INO
NASDAQHealthcareBiotechnology$1.66-1.19%
A clinical-stage biotechnology company developing DNA-based immunotherapies and vaccines delivered using proprietary electroporation technology. Its pipeline targets infectious diseases, HPV-related cancers, and other indications, with value largely tied to clinical trial outcomes, regulatory milest...
Market Cap: $89.0M52W Range: $1.30 – $2.98
Congressional Interest in Inovio Pharmaceuticals, Inc. (INO)
4 members of Congress have disclosed 4 trades in Inovio Pharmaceuticals, Inc. (INO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
4
Buys
2
Sells
2
Who in Congress Is Trading INO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-09-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2018-06-25 | Chris Collins | buy | $15K – $50K |